A Study of HS-20094 in T2DM Participants

Clinical trial NCT06118008 · COMPLETED

Trial details

NCT number: NCT06118008
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2023-05-31
Primary completion: 2024-01-04
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.